Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

Apr 24, 2019

SELL
$3.2 - $4.19 $32,003 - $41,904
-10,001 Closed
0 $0
Q4 2018

Feb 01, 2019

SELL
$2.8 - $4.22 $560 - $844
-200 Reduced 1.96%
10,001 $34,000
Q3 2018

Oct 25, 2018

BUY
$3.5 - $4.91 $700 - $982
200 Added 2.0%
10,201 $44,000
Q2 2018

Jul 20, 2018

SELL
$3.22 - $4.43 $2,633 - $3,623
-818 Reduced 7.56%
10,001 $37,000
Q4 2017

Jan 17, 2018

SELL
$3.88 - $6.96 $34,920 - $62,640
-9,000 Reduced 45.41%
10,819 $64,000
Q3 2017

Oct 17, 2017

BUY
$2.91 - $4.71 $57,673 - $93,347
19,819
19,819 $85,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $441M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.